Daniel L Rudnicki Selected Research

doxazolidine

7/2012	Synthesis and biological characterization of protease-activated prodrugs of doxazolidine.
12/2009	Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine.
1/2008	Anthracycline-formaldehyde conjugates and their targeted prodrugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel L Rudnicki Research Topics

Disease

3	Neoplasms (Cancer) 07/2012 - 01/2008
1	Cardiotoxicity 07/2012
1	Thyroid Neoplasms (Thyroid Cancer) 12/2009
1	Colonic Neoplasms (Colon Cancer) 01/2008

Drug/Important Bio-Agent (IBA)

3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2012 - 01/2008
3	doxazolidineIBA 07/2012 - 01/2008
2	ProdrugsIBA 07/2012 - 12/2009
2	pentyl 4- (N- doxazolidinylcarbonyloxymethyl)phenylcarbamateIBA 12/2009 - 01/2008
1	Cathepsin BIBA 07/2012
1	Fibrinolysin FDA Link 07/2012
1	Peptide Hydrolases (Proteases)FDA Link 07/2012
1	TrypsinIBA 07/2012
1	AnthracyclinesIBA 07/2012
1	Formaldehyde (Formol)FDA Link 12/2009
1	Carboxylesterase (Hydrolase S)IBA 12/2009
1	Tuberculin (PPD)IBA 12/2009
1	Biomarkers (Surrogate Marker)IBA 12/2009
1	doxoformIBA 01/2008
1	EnzymesIBA 01/2008